MEDPRO SYSTEMS
LIVE

Serial Number

99740809

Owner

MedPro Systems LLC

Attorney

Christine Amara

First Use Date

Jun 11, 2025

Filing Date

Apr 2, 2026

Add to watchlist:

No watchlists yet
View on USPTO

MEDPRO SYSTEMS Trademark

Serial Number: 99740809

MEDPRO SYSTEMS is a trademark filed by MedPro Systems LLC on April 2, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently pending registration.

Owner Contact Info

MedPro Systems LLC (43 trademarks)

100 VALLEY ROAD, Suite 201
Mt. Arlington, NJ 07856

Entity Type: 10

Trademark Details

Filing Date

April 2, 2026

Registration Date

Not Registered

First Use Anywhere

June 11, 2025

First Use in Commerce

June 11, 2025

Goods & Services

(Based on Use) Software as a service (SaaS) services featuring software for use to assist in tracking and reporting healthcare practitioner and healthcare organization interactions and complying with international, federal, state and local spend and transparency laws and regulations; software as a service (SaaS) services featuring software to assist pharmaceutical, biotechnology and medical device companies in managing, validating and enriching healthcare organization and healthcare practitioner data attributes in connection with regulatory compliance, sales and marketing effort (Based on Intent to Use) Software as a service (SaaS) services featuring software to assist pharmaceutical, biotechnology and medical device companies to manage healthcare professional engagement activities and workflows; Software as a service (SaaS) services featuring software to assist pharmaceutical, biotechnology and medical device companies with healthcare professional fair market value tiering and compensation oversight.

Regulatory support in the field of life sciences, pharmaceuticals, biotechnology, and medical devices; consulting services to assist life sciences, pharmaceutical, biotechnology and medical device companies in the fields of regulatory compliance, namely, compliance in the areas of aggregate spend disclosure reporting, the Prescription Drug Marketing Act, the Drug Supply Chain Security Act, Condition of Participation for Outpatient Services, Stark Law and Ohio Terminal Distributor of Dangerous Drugs requirements; online searchable databases and information concerning laws, regulations, and guidance documents for the life sciences industry; regulatory compliance consulting services in the field of aggregate spend disclosure reporting; regulatory and compliance information for pharmaceutical, biotechnology and medical device companies, and for entities involved in the drug and device supply chain, regarding transparency and aggregate spend, marketing, and other compliance requirements

Filing History

APPLICATION FILING RECEIPT MAILED
Apr 2, 2026 MAFR
NEW APPLICATION ENTERED
Apr 2, 2026 NWAP